Skip to main content
Log in

Quality assessment of umbilical cord blood units at the time of transplantation

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Total nucleated cell (TNC) count, CD34+ cell count, colony-forming unit-granulocyte–macrophage (CFU-GM) content, and cell viability impact the outcome of umbilical cord blood (UCB) transplantation. Assessments of unit quality have usually been provided by cord blood banks (CBBs), but it is unclear whether pre-freezing tests or pre-transplant release tests performed by CBBs are reproducible. The aim of this study was to compare the UCB characteristics analyzed at the site of infusion of the UCB with those provided by CBBs. Samples were taken from 54 UCB units for assessment of post-thaw characteristics. TNC counts and CD34+ cell contents measured at our hospital before infusion showed good correlations with values assessed in pre-freezing tests (r = 0.900 and 0.943, respectively) and pre-transplant release tests (r = 0.829 and 0.930, respectively). Our data reveal that the TNC counts and CD34+ cell contents determined by pre-freezing and pre-transplant release tests, which are the most important UCB unit selection criteria, accurately reflected the quality of infused UCB units. However, CFU-GM content was poorly correlated (r = 0.560 and 0.606). Correlation of post-thaw cell viabilities measured before infusion and during the pre-transplant release tests was also poor (r = 0.308). We suggest that the TNC count and CD34+ cell content estimated before cryopreservation and in pre-transplant release tests provided by CBBs are reproducible and can assist the transplant physicians in selection of appropriate UCB units.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–8.

    CAS  PubMed  Google Scholar 

  2. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75.

    Article  CAS  PubMed  Google Scholar 

  3. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.

    Article  CAS  PubMed  Google Scholar 

  4. Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104:3813–20.

    Article  CAS  PubMed  Google Scholar 

  5. Eapen M, Rocha V, Sanz G, et al. Effects of graft source on unrelated donor haematopoietic stem-cell transplantation in adults with acute leukemia: a retrospective analysis. Lancet Oncol. 2010;11:653–60.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Picardi A, Arcese W. Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. Transfus Apheresis Sci. 2010;42:289–97.

    Article  Google Scholar 

  7. McCullough J, McKenna D, Kadidlo D, et al. Issues in the quality of umbilical cord blood stem cells for transplantation. Transfusion. 2005;45:832–41.

    Article  PubMed  Google Scholar 

  8. Wagner E, Duval M, Dalle J-H, et al. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion. 2006;46:1190–8.

    Article  PubMed  Google Scholar 

  9. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry. 1998;34:61–70.

    Article  CAS  PubMed  Google Scholar 

  10. Itoh T, Minegishi M, Fushimi J, et al. A simple controlled-rate freezing method without a rate-controlled programmed freezer provides optimal conditions for both large scale and small scale of umbilical cord blood cells. Transfusion. 2003;43:1303–8.

    Article  PubMed  Google Scholar 

  11. Querol S, Gomez SG, Pagliuca A, et al. Quality rather than quantity: the cord blood bank dilemma. Bone Marrow Transplant. 2010;45:970–8.

    Article  CAS  PubMed  Google Scholar 

  12. Stevens CE, Gladstone J, Taylor PE, et al. Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood. 2002;100:2662–4.

    Article  CAS  PubMed  Google Scholar 

  13. Nagamura-Inoue T, Shioya M, Sugo M, et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion. 2003;43:1285–94.

    Article  PubMed  Google Scholar 

  14. Yang H, Acker JP, Hannon J, Miszta-Lane H, Akabutu JJ, McGann LE. Damage and protection of UC blood cells during cryopreservation. Cytotherapy. 2001;3:377–86.

    Article  CAS  PubMed  Google Scholar 

  15. Allan DS, Keeney M, Howson-Jan K, et al. Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:967–72.

    Article  CAS  PubMed  Google Scholar 

  16. Gratama JW, Kraan J, Keeney M, et al. Validation of the single-platform ISHAGE method for CD34+ hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy. 2003;5:55–65.

    Article  CAS  PubMed  Google Scholar 

  17. Donaldson C, Armitage WJ, Denning-Kendall PA, Nicol AJ, Bradley BA, Hows JM. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant. 1996;18:725–31.

    CAS  PubMed  Google Scholar 

  18. Kudo Y, Minegishi M, Itoh T, et al. Evaluation of hematological reconstitution potential of autologous peripheral blood progenitor cells cryopreserved with a simple controlled-rate freezing method. Tohoku J Exp Med. 2005;205:37–43.

    Article  PubMed  Google Scholar 

  19. Iori AP, Cerretti R, De Felice M, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. Bone Marrow Transplant. 2004;33:1097–105.

    Article  CAS  PubMed  Google Scholar 

  20. Minegishi M, Itoh T, Fukawa N, et al. Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer. Int J Hematol. 2007;85:78–84.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We are very grateful to Ms. S. Aoki for her technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayoshi Minegishi.

About this article

Cite this article

Kudo, Y., Minegishi, M., Seki, O. et al. Quality assessment of umbilical cord blood units at the time of transplantation. Int J Hematol 93, 645–651 (2011). https://doi.org/10.1007/s12185-011-0830-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-011-0830-y

Keywords

Navigation